Form4.ai tracks every SEC insider trade in real time. See every ZNTL insider filing with a free account — no card.
See every ZNTL insider filing — free account, no card.
Free accountZentalis Pharmaceuticals, Inc. (ZNTL) has 2 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $15.2M. Most recent filing: Oct. 1, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 1, 2026 SEC filing | Bruns Ingmar Chief Medical Officer | Grant / award | $21,205 | — |
| Aug 19, 2026 SEC filing | WALTERS GROUP 10% Owner | Bought | $15,172,500 | -10.6% 30D |
Create a free account to see all 2 ZNTL filings from the last 90 days. No card needed.
Create free accountWant ZNTL insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.